KELLI MOSHER: Open Payments
NPI 1578784005 · ASHEBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$575 in 27 payments from 20 companies in 2025. Trend: 2023 $52 · 2024 $346 · 2025 $575
Food & beverage: $575
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $52 |
| Eisai Inc. | 2 | $50 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| PFIZER INC. | 2 | $45 |
| Merck Sharp & Dohme LLC | 2 | $43 |
| GENZYME CORPORATION | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| ARRAY BIOPHARMA INC | 1 | $26 |
| Aveo Pharmaceuticals, Inc. | 1 | $24 |
| PharmaEssentia USA Corporation | 1 | $24 |
Products named: OPDIVO, Lenvima, KEYTRUDA, SARCLISA, LIBTAYO, LORBRENA, SCEMBLIX, XTANDI.
Industry payments across NC — which companies pay providers there.
